Nicotrol and Nicoderm nicotine patches recommended for OTC approval.
This article was originally published in The Tan Sheet
Executive Summary
NICOTROL AND NICODERM UNANIMOUSLY RECOMMENDED FOR OTC USE on April 19 by FDA's Nonprescription Drugs Advisory Committee, which was joined by members of the agency's Drug Abuse Advisory Committee. In separate votes on the two products, the committee voted 9-0 that McNeil Consumer Products' Nicotrol and SmithKline Beecham's Nicoderm nicotine transdermal patches are safe and effective for over-the-counter use as smoking cessation aids.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning